468

By now I suppose everyone thinks that I am employed by one of the GLP-1RA marketing firms. I have still not decided exactly where to fit this exciting new drug in the armamentarium of a wound care practitioner, but so far the drugs have potential use in just about every underlying problem we see on a daily basis: obesity, diabetes, sleep apnea, renal disease, chronic inflammation and perhaps – peripheral arterial disease (PAD). Chronic wounds (and edema) are really symptoms of those conditions.

Maybe at the very least, we can encourage patients to talk to their primary care doctor about trying one of them.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.